Homma Y - Search Results

1

Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer.

Gong X, Siprashvili Z, Eminaga O, Shen Z, Sato Y, Kume H, Homma Y, Ogawa S, Khavari PA, Pollack JR, Brooks JD. Gong X, et al. Among authors: homma y. Oncotarget. 2017 Mar 21;8(12):18657-18669. doi: 10.18632/oncotarget.15703. Oncotarget. 2017. PMID: 28423633 Free PMC article.

2

Late recurrence of uterine endometrioid carcinoma in the upper urinary tract.

Tsurumaki Y, Kume H, Homma Y. Tsurumaki Y, et al. Among authors: homma y. Arch Gynecol Obstet. 2009 Oct;280(4):631-2. doi: 10.1007/s00404-009-0949-8. Epub 2009 Feb 7. Arch Gynecol Obstet. 2009. PMID: 19198862

3

Fujimura T, Takahashi S, Kume H, Takeuchi T; Clinical Study Group of Tokyo University Affiliated Hospitals; Kitamura T, Homma Y. Fujimura T, et al. Among authors: homma y. Int J Urol. 2009 May;16(5):522-5. doi: 10.1111/j.1442-2042.2009.02291.x. Epub 2009 Apr 6. Int J Urol. 2009. PMID: 19383037

4

Near infrared spectroscopy study of the central nervous activity during artificial changes in bladder sensation in men.

Matsumoto S, Ishikawa A, Kume H, Takeuchi T, Homma Y. Matsumoto S, et al. Among authors: homma y. Int J Urol. 2009 Sep;16(9):760-4. doi: 10.1111/j.1442-2042.2009.02358.x. Epub 2009 Aug 5. Int J Urol. 2009. PMID: 19674164

5

WITHDRAWN: Relationships between 8q24 and 17q risk loci and sporadic or latent prostate cancer and the impacts of these loci on the clinicopathologic characteristics of prostate cancer.

Liu M, Suzuki M, Kurosaki T, Kume H, Ishikawa A, Enomoto Y, Nishimatsu H, Fukuhara H, Fujimura T, Arai T, Sawabe M, Homma Y, Kitamura T. Liu M, et al. Among authors: homma y. Biochem Biophys Res Commun. 2009 Dec 21. doi: 10.1016/j.bbrc.2009.12.071. Online ahead of print. Biochem Biophys Res Commun. 2009. PMID: 20026053

6

Distant metastasis of renal cell carcinoma with a diameter of 3 cm or less-which is aggressive cancer?

Kume H, Suzuki M, Fujimura T, Fukuhara H, Enomoto Y, Nishimatsu H, Homma Y. Kume H, et al. Among authors: homma y. J Urol. 2010 Jul;184(1):64-8. doi: 10.1016/j.juro.2010.03.019. Epub 2010 May 15. J Urol. 2010. PMID: 20478591

7

Successful treatment of metastatic malignant fibrous histiocytoma of the kidney.

Sugihara T, Fujimura T, Kume H, Homma Y. Sugihara T, et al. Among authors: homma y. Urol Int. 2010;85(1):118-20. doi: 10.1159/000315874. Epub 2010 Jun 1. Urol Int. 2010. PMID: 20516674

8

Ribonucleotide reductase M2 subunit is a novel diagnostic marker and a potential therapeutic target in bladder cancer.

Morikawa T, Maeda D, Kume H, Homma Y, Fukayama M. Morikawa T, et al. Among authors: homma y. Histopathology. 2010 Dec;57(6):885-92. doi: 10.1111/j.1365-2559.2010.03725.x. Histopathology. 2010. PMID: 21166702

9

Docetaxel as a vital option for corticosteroid-refractory prostate cancer.

Kume H, Suzuki M, Fujimura T, Fukuhara H, Enomoto Y, Nishimatsu H, Ishikawa A, Homma Y. Kume H, et al. Among authors: homma y. Int Urol Nephrol. 2011 Dec;43(4):1081-7. doi: 10.1007/s11255-011-9922-0. Epub 2011 Mar 11. Int Urol Nephrol. 2011. PMID: 21394439

10

Prognostic factors for renal cell carcinoma with bone metastasis: who are the long-term survivors?

Kume H, Kakutani S, Yamada Y, Shinohara M, Tominaga T, Suzuki M, Fujimura T, Fukuhara H, Enomoto Y, Nishimatsu H, Homma Y. Kume H, et al. Among authors: homma y. J Urol. 2011 May;185(5):1611-4. doi: 10.1016/j.juro.2010.12.037. Epub 2011 Mar 17. J Urol. 2011. PMID: 21419440

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,354 results

Search Page

Filters